Literature DB >> 17318017

TTF-2/FOXE1 gene polymorphisms in Sicilian patients with permanent primary congenital hypothyroidism.

L Santarpia1, M Valenzise, G Di Pasquale, T Arrigo, G San Martino, M P Cicciò, F Trimarchi, F De Luca, S Benvenga.   

Abstract

Thyroid transcription factor-2 (TTF-2/FOXE1) is a polyalanine domain protein that regulates thyroid embryogenesis, but very few patients with permanent primary congenital hypothyroidism (pCH) harbor germline mutations of this or other transcription factors that are involved in thyroid development that might explain the etiology of pCH. Variations within the polyalanine tract are found in a variety of genes and are often reported in association with malformation syndromes; pCH is frequently associated with thyroid malformations and extra-thyroidal malformations. Therefore, in this study we investigated whether alanine (Ala) length polymorphisms and non-polymorphic mutations of the TTF-2 gene in pCH patients might be involved in the pathogenesis of pCH. The entire coding region of the TTF-2 gene was analyzed in 57 Sicilian patients and 142 healthy controls. We found that the homozygous Ala14 polymorphism (Ala14/14) was less frequent in the pCH group than in the controls. In contrast, significantly more pCH patients than controls harbored the Ala16 polymorphism (Ala16/16 and Ala14/16). However, neither the Ala14/14 nor the Ala16 polymorphism was related to extra-thyroidal malformations. Two of the 57 patients carried Ala11/14 and Ala12/14, and one Ala14/14 patient also had the silent polymorphism 387 C/T (Leu129Leu). Other than known polymorphic variants we found no mutation in the TTF-2 gene. Therefore, this study demonstrates that mutations in the TTF-2 gene are rare in pCH patients and suggests that variations in the length of the Ala-tract could at least partially explain the etiology of pCH but not that of extra-thyroidal malformations.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17318017     DOI: 10.1007/bf03347390

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  29 in total

1.  Genetic epidemiology of single-nucleotide polymorphisms.

Authors:  A Collins; C Lonjou; N E Morton
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

2.  Linkage disequilibrium and the mapping of complex human traits.

Authors:  Kenneth M Weiss; Andrew G Clark
Journal:  Trends Genet       Date:  2002-01       Impact factor: 11.639

3.  Missense mutation in the transcription factor NKX2-5: a novel molecular event in the pathogenesis of thyroid dysgenesis.

Authors:  Monica Dentice; Viviana Cordeddu; Annamaria Rosica; Alfonso Massimiliano Ferrara; Libero Santarpia; Domenico Salvatore; Luca Chiovato; Anna Perri; Lidia Moschini; Cristina Fazzini; Antonella Olivieri; Pietro Costa; Vera Stoppioni; Mariangiola Baserga; Mario De Felice; Mariella Sorcini; Gianfranco Fenzi; Roberto Di Lauro; Marco Tartaglia; Paolo Emidio Macchia
Journal:  J Clin Endocrinol Metab       Date:  2006-01-17       Impact factor: 5.958

Review 4.  Congenital hypothyroidism: from paracelsus to molecular diagnosis.

Authors:  Anissa Djemli; Guy Van Vliet; Edgard E Delvin
Journal:  Clin Biochem       Date:  2006-04-20       Impact factor: 3.281

5.  A novel mutation (Q40P) in PAX8 associated with congenital hypothyroidism and thyroid hypoplasia: evidence for phenotypic variability in mother and child.

Authors:  T Congdon; L Q Nguyen; C R Nogueira; R L Habiby; G Medeiros-Neto; P Kopp
Journal:  J Clin Endocrinol Metab       Date:  2001-08       Impact factor: 5.958

6.  Polymorphism of the polyalanine tract of thyroid transcription factor-2 gene in patients with thyroid dysgenesis.

Authors:  A Hishinuma; Y Ohyama; T Kuribayashi; N Nagakubo; T Namatame; K Shibayama; O Arisaka; N Matsuura; T Ieiri
Journal:  Eur J Endocrinol       Date:  2001-10       Impact factor: 6.664

7.  A novel loss-of-function mutation in TTF-2 is associated with congenital hypothyroidism, thyroid agenesis and cleft palate.

Authors:  Mireille Castanet; Soo-Mi Park; Aaron Smith; Michel Bost; Juliane Léger; Stanislas Lyonnet; Anna Pelet; Paul Czernichow; Krishna Chatterjee; Michel Polak
Journal:  Hum Mol Genet       Date:  2002-08-15       Impact factor: 6.150

8.  Polymorphism, shared functions and convergent evolution of genes with sequences coding for polyalanine domains.

Authors:  Hugo Lavoie; Francois Debeane; Quoc-Dien Trinh; Jean-Francois Turcotte; Louis-Philippe Corbeil-Girard; Marie-Josée Dicaire; Anik Saint-Denis; Martin Pagé; Guy A Rouleau; Bernard Brais
Journal:  Hum Mol Genet       Date:  2003-09-30       Impact factor: 6.150

9.  An investigation into FOXE1 polyalanine tract length in premature ovarian failure.

Authors:  Wendy J Watkins; Sarah E Harris; Megan J Craven; Andrea L Vincent; Ingrid M Winship; Ksenija Gersak; Andrew N Shelling
Journal:  Mol Hum Reprod       Date:  2006-02-15       Impact factor: 4.025

10.  Congenital anomalies concomitant with persistent primary congenital hypothyroidism.

Authors:  R Siebner; P Merlob; I Kaiserman; J Sack
Journal:  Am J Med Genet       Date:  1992-09-01
View more
  8 in total

1.  FOXE1 polymorphisms: a new piece in the puzzle of thyroid dysgenesis.

Authors:  P E Macchia
Journal:  J Endocrinol Invest       Date:  2007-01       Impact factor: 4.256

Review 2.  The molecular causes of thyroid dysgenesis: a systematic review.

Authors:  I C Nettore; V Cacace; C De Fusco; A Colao; P E Macchia
Journal:  J Endocrinol Invest       Date:  2013-05-22       Impact factor: 4.256

3.  A novel formulation of L-thyroxine (L-T4) reduces the problem of L-T4 malabsorption by coffee observed with traditional tablet formulations.

Authors:  Roberto Vita; Giovanna Saraceno; Francesco Trimarchi; Salvatore Benvenga
Journal:  Endocrine       Date:  2012-08-30       Impact factor: 3.633

Review 4.  Thyroid transcription factors in development, differentiation and disease.

Authors:  Lara P Fernández; Arístides López-Márquez; Pilar Santisteban
Journal:  Nat Rev Endocrinol       Date:  2014-10-28       Impact factor: 43.330

5.  Polymorphic length of FOXE1 alanine stretch: evidence for genetic susceptibility to thyroid dysgenesis.

Authors:  Aurore Carré; Mireille Castanet; Sylvia Sura-Trueba; Gabor Szinnai; Guy Van Vliet; Delphine Trochet; Jeanne Amiel; Juliane Léger; Paul Czernichow; Virginie Scotet; Michel Polak
Journal:  Hum Genet       Date:  2007-08-24       Impact factor: 4.132

6.  FOXE1 polyalanine tract length screening by MLPA in idiopathic premature ovarian failure.

Authors:  Chun-rong Qin; Ji-long Yao; Wen-jie Zhu; Wei-qing Wu; Jian-sheng Xie
Journal:  Reprod Biol Endocrinol       Date:  2011-12-16       Impact factor: 5.211

7.  Rtfc (4931414P19Rik) Regulates in vitro Thyroid Differentiation and in vivo Thyroid Function.

Authors:  Yang Yu; Chang Liu; Junxia Zhang; Mimi Zhang; Wei Wen; Xianhui Ruan; Dapeng Li; Shuang Zhang; Ming Gao; Lingyi Chen
Journal:  Sci Rep       Date:  2017-02-23       Impact factor: 4.379

8.  Further Evidence That Defects in Main Thyroid Dysgenesis-Related Genes Are an Uncommon Etiology for Primary Congenital Hypothyroidism in Mexican Patients: Report of Rare Variants in FOXE1, NKX2-5 and TSHR.

Authors:  Miguel Angel Alcántara-Ortigoza; Iraís Sánchez-Verdiguel; Liliana Fernández-Hernández; Sergio Enríquez-Flores; Aidy González-Núñez; Nancy Leticia Hernández-Martínez; Carmen Sánchez; Ariadna González-Del Angel
Journal:  Children (Basel)       Date:  2021-05-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.